ΔF508 in cystic fibrosis: Willing but not able

Archives of Disease in Childhood

Volumn 76, Issue 3, 1997, Pages 278-282

  Southern, Kevin W ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ARYLBUTYRIC ACID DERIVATIVE; GLYCEROL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CHILD; CYSTIC FIBROSIS; GENE MUTATION; GENE THERAPY; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030887196     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.76.3.278     Document Type: Review

References (49)

1. Anderson MP, Gregory RJ, Thompson S, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991;253:202-5.
2. Bear CE, Li CH, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh M. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992;68:809-18.
3. Schwiebert EM, Egan ME, Hwang TH, et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 1995;81:1063-73.
4. Stutts MJ, Canessa CM, Olsen JC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995;269: 847-50.
5. Tsui L-C, Buchwald M, Barker D, et al. Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science 1985;230:1054-57.
6. Roberts L. The race for the cystic fibrosis gene. Science 1988;240:141-4, 282-5.
7. Rommens JM, Iannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989;245:1059-65.
8. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
9. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-9.
10. Sferra TJ, Collins FS. The molecular biology of cystic fibrosis. Annu Rev Med 1993;44:133-44.
11. Bowler IM, Estlin EJ, Littlewood JM. Cystic fibrosis in asians. Arch Dis Child 1993;68:120-2.
12. Serre JL, Simon-Bouy B, Mornet E, et al. Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in populations genetics. Hum Genet 1990;84:449-54.
13. Morral N, Bertranpetit J, Estivill X, et al. The origin of the major cystic fibrosis mutation (deltaF508) in European populations. Nat Genet 1994;7:I69-75.
14. Romeo G, Devoto M, Galietta LJ. Why is the cystic fibrosis gene so frequent? Hum Genet 1989;84:1-5.
15. Guggino SE. Gates of Janus: cystic fibrosis and diarrhoea. Trends Microbiol 1994;2:91-4.
16. Gabriel SE, Brigman KN, Koller BH, Boucher RC, Jackson Stutts M. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 1994;266: 107-9.
17. Cuthbert AW, Halstead J, Ratcliff R, Colledge WH, Evans MJ. The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study. J Physiol 1995;482:449-54.
18. Schroeder SA, Gaughan DM, Swift M. Protection against bronchial asthma by CFTR ΔF508 mutation: a heterozygote advantage in cystic fibrosis. Nat Med 1995;1:703-5.
19. Mennie M, Gilfillan A, Brock DJH, Liston WA. Heterozygotes for the ΔF508 cystic fibrosis allele are not protected against bronchial asthma. Nat Med 1995;1:978-9.
20. Cheng SH, Gregory RJ, Marshall J, et al. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-34.
21. Lukacs GL, Mohamed A, Kartner N, Chang X, Riordan JR, Grinstein S. Conformational maturation of CFTR but not its mutant counterpart (ΔF508) occurs in the endoplasmic reticulum and requires ATP. EMBO J 1995;13:6076-86.
22. Yang Y, Janich S, Cohn JA, Wilson JM. The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi non-lysosomal compartment. Proc Natl Acad Sci USA 1993;90:9480-4.
23. Lukacs GL, Chang X, Bear CE, et al. The ΔF508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. J Biol Chem 1993;268:21592-8.
24. Ward CL, Kopito RR. Intracellular turnover of cystic fibrosis transmembrane conductance regulator. J Biol Chem 1994;269:25710-8.
25. Thomas PJ, Shenbagamurthi P, Ysern X, Pedersen PL. Cystic fibrosis transmembrane conductance regulator: nucleotide binding to a synthetic peptide. Science 1991;251: 555-7.
26. Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992;355:33-45.
27. Ou W, Cameron PH, Thomas DY, Bergeron JJM. Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 1993;364:771-6.
28. Beckmann RP, Mizzen LA, Welch WJ. Interaction of hsp70 with newly synthesized proteins: implications for protein folding and assembly. Science 1990;248:850-4.
29. Jackson MR, Cohen-Doyle MF, Peterson PA, Williams DB. Regulation of MHC class 1 transport by the molecular chaperone, calnexin (p88,IP90). Science 1994;263:384-7.
30. Pind S, Riordan JR, Williams DB. Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator. J Biol Chem 1994;269:12784-8.
31. Drumm ML, Pope HA, Cliff WH, et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell 1990;62:1227-33.
32. Rich DP, Anderson MP, Gregory RJ, et al. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990;347:358-63.
33. Drumm ML, Wilkinson DJ, Smit LS, et al. Chloride conductance expressed by ΔF508 and other mutant CFTRs in xenopus oocytes. Science 1991;254:1797-9.
34. Dalemans W, Barbry P, Champigny G, et al. Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation. Nature 1991;354:526-8.
35. Machamer CE, Rose JK. Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulphide bonding. J Biol Chem 1988;263:5955-60.
36. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature sensitive. Nature 1992;358:761-4.
37. Egan ME, Schwiebert EM, Guggino WB. Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells. Am J Physiol 1995; 268(Cell Physiol 37):C243-51.
38. Hartman J, Huang Z, Rado TA, et al. Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. J Biol Chem 1992;267:6455-8.
39. Pasyk EA, Foskett JK. Mutant (deltaF508) cystic fibrosis conductance regulator chloride channel is functional when retained in endoplasmic reticulum of mammalian cells. J Biol Chem 1995;270:12347-50.
40. Li C, Ramjeesingh M, Reyes E, et al. The cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR. Nat Genet 1993;3:311-6.
41. Colledge WH, Abella BS, Southern KW, et al. Generation and characterization of a ΔF508 cystic fibrosis mouse model. Nat Genet 1995;10:445-52.
42. Gill DR, Southern KW, Mofford KA, et al. A placebo controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997 (in press).
43. Knowles MR, Hohneker KW, Zhou Z, et al . A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 1995;333:823-31.
44. Cheng SH, Fang SL, Zabner J, et al. Functional activation of the cystic fibrosis trafficking mutant ΔF508-CFTR by overexpression. Am J Physiol 1995;268:L615-24.
45. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 1996;271: 635-8.
46. Eidelman O, Guay-Broder C, van Galen PJM, et al. A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. Proc Natl Acad Sci USA 1992;89: 5562-6.
47. Guay-Broder C, Jacobsen KA, Barnoy S, et al. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator ΔF508. Biochemistry 1995;34:9079-87.
48. Burgoyne RD. Trimeric G proteins in golgi transport. Trends Biochem Sci 1992;17:87-8.
49. Schwiebert EM, Gesek F, Ercolani L, et al. Heterotrimeric G proteins, vesicle trafficking, and CFTR chloride channels. Am J Physiol 1994;267(Cell Physiol 36):C272-81.